Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07270211 · ClinicalTrials.gov registry record
MCG In Long QT Syndrome
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 100
- Enrollment target
NCT07270211: Clinical Trial study, sponsored by Mayo Clinic.
NCT07270211 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07270211 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.
Interventions
- DIAGNOSTIC_TEST Magnetocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07270211
The ClinicalTrials.gov registry entry for NCT07270211 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetocardiography is the first listed.
NCT07270211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07270211 about?
NCT07270211 is a clinical study titled "MCG In Long QT Syndrome". The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG...
What is the current status of trial NCT07270211?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-04. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07270211?
The interventions under investigation include: Magnetocardiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07270211?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.